Questions for the next quarterly update
On April 1, 2021, management published an investor presentation and stated, among other things, the following milestones to be achieved by the end of May:
Finalize due diligence and agree on terms with new organization
Finalize Tinyi agreement
What led management to believe that negotiations with a Chinese company for the development of TFC 1067 would be completed by the end of May?
What are the results of the due diligence?
What is the status of the negotiations with the Chinese company?
Why has the Tinyi agreement not yet been finalized?
What is the status of negotiations with Tinyi?
In the current investor presentation it now says
Establish terms with new organization in China for TFC-1067
Why was this changed?
Why is it now called establish and not finalize?
How can this be 6 months after end of May?
Completed an additional licensing agreement for the SGLT2 inhibitor in new markets
This agreement was already announced for Christmas 2020. How did this happen? Why did management assume that a contract could be signed by Christmas 2020?
In the meantime, we have been informed that there are problems with production. Has the project failed?
What is the status of negotiations with the 2 or now 4 global partners?
Secure non-dilutive funding through anticipated collaborations
Does this mean that warrant holders are being persuaded to exercise their warrants shortly before they expire by fabricated stories?
Complete Phase I clinical trial in China for the SGLT2 Inhibitor and advance to Phase II
Why have the results not yet been announced?
If Phase I had been successfully completed, would the results have been announced?
Why is Wanbang withholding the results? Are they allowed to do that?
If the results have not been announced after half a year, it can only mean that Phase I has failed. Wouldn't that be material information that should be published?
The following milestone was marked as complete
Begin large-scale manufacturing of TFC-1067 at a major manufacturer
What does large scale mean?
Who is the major manufacturer?
For whom is large scale produced?
Are there large scale sales in addition to the large scale production?
Shouldn't sales figures be published in the interim financial statements?
If so, why is the public kept in the dark about future sales figures?
What is management's view of future sales of TFC 1067 to R&F?
Does management believe there is no legitimate interest in any of the above questions? if so, which of the questions?
What effect does management think it has on credibility when it keeps coming up with new stories and promises and, after a lapse of time, leaves even the questions it raises simply unanswered?
Management posted a rocket 6 weeks ago on twitter announcing a strong newsflow.
What does strong newsflow mean?
Does flow indicate an increase in the number of news items?
Why was the rocket posted 6 weeks ago? Did it have something to do with the expiration of the warrants?
Management said an extensive du diligence was completed with a top10 pharma company. 6 weeks later it says there is further due diligence. Is this an indication that negotiations are delayed or have failed?